NCT00701987View on ClinicalTrials.gov

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Conditions
Melanoma
Interventions
DRUG

ALS-357

Topical application of ALS-357

Trial Locations (1)

60611

RECRUITING

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Sponsors
All Listed Sponsors
lead

Advanced Life Sciences, Inc.

INDUSTRY